HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis (Q40720204)

23 September 2017

title

HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis (English)

1 reference

23 September 2017

Keng-Hsin Lan

1 reference

23 September 2017

Meei-Ling Sheu

1 reference

23 September 2017

Shinn-Jang Hwang

1 reference

23 September 2017

Sang-Hue Yen

1 reference

23 September 2017

Shiow-Yi Chen

1 reference

23 September 2017

Jaw-Ching Wu

1 reference

23 September 2017

Yuan-Jan Wang

1 reference

23 September 2017

Naoya Kato

1 reference

23 September 2017

Masao Omata

1 reference

23 September 2017

Full-Young Chang

1 reference

23 September 2017

Shou-Dong Lee

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

23 September 2017

1 reference

23 September 2017

1 reference

23 September 2017

1 reference

23 September 2017

page(s)

4801-4811

1 reference

Genetic organization and diversity of the hepatitis C virus

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Thymocyte apoptosis induced by p53-dependent and independent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Wild-type p53 can inhibit oncogene-mediated focus formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

The p53 proto-oncogene can act as a suppressor of transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Mutational hot spot in the p53 gene in human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Reduced binding of TFIID to transcriptionally compromised mutants of VP16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

21 January 2018

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Cancer. p53, guardian of the genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

T antigen is bound to a host protein in SY40-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

The tumor suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

p53 is required for radiation-induced apoptosis in mouse thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Human TAFII31 protein is a transcriptional coactivator of the p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Activation of p53 tumor suppressor by hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

p53 and tumour viruses: catching the guardian off-guard

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Efficient selection for high-expression transfectants with a novel eukaryotic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Hepatitis B x protein inhibits p53-dependent DNA repair in primary mouse hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Transcriptional repression of p53 promoter by hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease(s) in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

New insights into the mechanism of inhibition of p53 by simian virus 40 large T antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

The Amino Terminal Deletion Mutants of Hepatitis C Virus Nonstructural Protein NS5A Function as Transcriptional Activators in Yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Apoptosis in the pathogenesis and treatment of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Inhibition of hepatitis-B-virus core promoter by p53: implications for carcinogenesis in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Functional inactivation but not structural mutation of p53 causes liver cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Induced alpha helix in the VP16 activation domain upon binding to a human TAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Adenovirus serotype determines association and localization of the large E1B tumor antigen with cellular tumor antigen p53 in transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

7 January 2021

p53 status and the efficacy of cancer therapy in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

7 January 2021

Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

7 January 2021

p53-dependent apoptosis suppresses tumor growth and progression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205589

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205589

1 reference

Dimensions Publication ID

23 September 2017

1035125877

0 references

1 reference